Technology and Humanity in Healthcare: 3-part Webinar Series
Hello FHSS SIM Group Members –
David Wortley (david@davidwortley.com) is presenting: Technology and Humanity in Healthcare: 3-part Webinar Series
Wednesday 10 May ’23 at 12 noon BST.
Please register at
See info below.
Hope to see you in Zoom. The link is to follow.
Yours, Anthony Basiel
~~~~~~~~~~~~~~~~~~~~~/
Technology and Humanity in Healthcare: 3-part Webinar Series
When: 12noon – 1pm BST
May 10th – The role of AI and VR in Nursing Education
June 15th – Metaverse and Health and Wellbeing
July 12th – Technology, Humanity and the Ageing Society (Preventative Healthcare, Dementia, lifestyle medicine)
Event detail/description:
This interactive webinar series addresses technology and humanity issues in healthcare. The engaging webinar interview format is in two parts: a) David Wortley provides (Via Zoom) some healthcare/tech questions and context to stimulate debate. B) Debbie and/or Anthony will follow-with some pre-set questions and any new questions from the audience text chat. The default protocol is that all audience members in Zoom will have video and sound off – text chat Q&A. A Text Chat Facilitator passes on any questions/comments to David for response. The event will be recorded
Doctoral Supervisors – Free UKCGE Webinar – Friday 1 May, 2pm
Innovate UK announce Digital Technology for Healthcare call










BU academics publish in Nepal national newspaper
New BU Physiology paper
Gender and street names
Help Shape the Future of Research at BU: Postgraduate Research Experience Survey 2026 Now Open
3C Event: Research Culture, Community & Cherry Blossom – Tuesday 14 April
REMINDER: 3MT® Competition – Deadline 9am Monday 20 April
ECR Funding Open Call: Research Culture & Community Grant – Apply now
ECR Funding Open Call: Research Culture & Community Grant – Application Deadline Friday 12 December
MSCA Postdoctoral Fellowships 2025 Call
ERC Advanced Grant 2025 Webinar
Update on UKRO services
European research project exploring use of ‘virtual twins’ to better manage metabolic associated fatty liver disease